Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CD9 |
| Upstream (Parents) |
|---|
| (<<) GALNT3 → CD9 |
| (<<) LGALS3 → CD9 |
| Downstream (Children) |
|---|
| CD9 → ABR (>>) |
| CD9 → TPI1 (>>) |
| CD9 → CLIC5 (>>) |
| CD9 → CCND2 (>>) |
| CD9 → EDN1 (>>) |
| CD9 → VDR (>>) |
| CD9 → ITGA2 (>>) |
| CD9 → PLBD1 (>>) |
| CD9 → FAR2 (>>) |
| CD9 → MYO1D (>>) |
